ATAD3A and head and neck squamous cell carcinoma: In contrast, ATAD3A overexpression increased phospho-ERK1/2 levels in HN12 cells (Fig. 4F), suggesting that ATAD3A has the potential to activate ERK1/2 in HNSCC cells.